MoneyWorks4Me

Supriya Lifescience - Quaterly Results

14 Feb 2023 Evaluate
The sales is pegged at Rs. 1051.40 millions for the December 2022 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 1170.00 millions during the year-ago period.The company suffered a huge decline of -75.99% to Rs. 95.17  millions from Rs. 396.39 millions  of corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 166.07 millions from 438.17 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 1051.40 1170.00 -10.14 3186.67 3418.00 -6.77 5300.49 3912.45 35.48
Other Income 25.64 54.42 -52.88 75.26 107.02 -29.68 75.77 49.77 52.24
PBIDT 166.07 438.17 -62.10 1043.57 1583.13 -34.08 2215.62 1781.51 24.37
Interest 10.14 11.49 -11.75 253.50 190.10 33.35 41.98 40.80 2.89
PBDT 155.93 426.68 -63.46 790.07 1393.03 -43.28 2173.64 1740.71 24.87
Depreciation 29.50 25.99 13.51 88.08 75.39 16.83 101.18 67.61 49.65
PBT 126.43 400.69 -68.45 701.99 1317.64 -46.72 2072.46 1673.10 23.87
TAX 31.26 4.30 626.98 185.70 261.65 -29.03 554.35 437.16 26.81
Deferred Tax 7.05 -119.86 -105.88 10.96 -75.79 -114.46 32.46 6.94 367.72
PAT 95.17 396.39 -75.99 516.29 1055.99 -51.11 1518.11 1235.94 22.83
Equity 160.97 160.96 0.01 160.97 160.96 0.01 160.97 146.37 9.97
PBIDTM(%) 15.80 37.45 -57.82 32.75 46.32 -29.30 41.80 45.53 -8.20
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..